Catalent to go disposable in new plant

Catalent sees a switch from stainless steel to single-use technology for bioprocessing components in its future, with a planned move next year to a new facility in Madison, WI. The move is intended to fortify the company's credentials as a biologic contract development and manufacturing organization. Announcement

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.